01 8ASSERTIO SPECLTY
01 810709844
01 8Blank
01 8Y
01 82029-03-10
Patent Expiration Date : 2029-03-10
US Patent Number : 10709844
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204824
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-10
Patent Expiration Date : 2029-03-10
US Patent Number : 10709844
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204824
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-10
Patent Expiration Date : 2029-03-10
US Patent Number : 10709844
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204824
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-10
Patent Expiration Date : 2029-03-10
US Patent Number : 10709844
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204824
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-10
Patent Expiration Date : 2029-03-10
US Patent Number : 10709844
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204824
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-10
Patent Expiration Date : 2029-03-10
US Patent Number : 10709844
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204824
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-10
Patent Expiration Date : 2029-03-10
US Patent Number : 10709844
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204824
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-10
Patent Expiration Date : 2029-03-10
US Patent Number : 10709844
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 204824
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-10
